Translational Development... (TDACU)

10.19

0.00 (0.02%)

At close: Mar 25, 2025, 9:34 AM

Translational Development Acquisition Cash Flow Statement

Table Mode

Year	FY23	FY22
Net Income	-485.55K	-70.66
Depreciation & Amortization	n/a	n/a
Stock-Based Compensation	n/a	n/a
Other Working Capital	3.01K	-75.08
Other Non-Cash Items	482.34K	0.00
Deferred Income Tax	n/a	n/a
Change in Working Capital	3.01K	-75.08
Operating Cash Flow	-204	-145.75
Capital Expenditures	n/a	n/a
Acquisitions	n/a	n/a
Purchase of Investments	n/a	n/a
Sales Maturities Of Investments	n/a	n/a
Other Investing Acitivies	n/a	n/a
Investing Cash Flow	n/a	n/a
Debt Repayment	n/a	n/a
Common Stock Repurchased	n/a	n/a
Dividend Paid	n/a	n/a
Other Financial Acitivies	n/a	149.08
Financial Cash Flow	n/a	149.08
Net Cash Flow	-204	n/a
Free Cash Flow	-204	-145.75